Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Stem Pharm
AddedFeb 19, 2024
UpdatedJun 18, 2026
Stem Pharm

Stem Pharm

Angel

Stem Pharm: Trusted supplier of synthetic biomaterials for advanced cellular models and regenerative medicine.

HQ
Madison, WI, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Stem Pharm, founded in 2015, is dedicated to supplying synthetic biomaterials tailored for advanced cellular models in drug discovery and regenerative medicine. The company focuses on engineering human biology to redefine neurologic drug discovery and modeling neuroinflammatory diseases with advanced in vitro models. Their offerings include human neural organoids with microglia for neuroimmune drug discovery, synthetic substrates like chemically-defined hydrogels, and comprehensive drug discovery services encompassing neurologic disease modeling, target discovery, phenotypic drug screening, and neurotoxicity assessments.

Stem Pharm has made significant strides in the field of synthetic biomaterials, becoming a trusted partner for researchers and pharmaceutical companies. Their innovative products and services have facilitated advancements in neurologic drug discovery and regenerative medicine, contributing to more effective and targeted therapeutic solutions. The company's impact is evident in its collaborations and partnerships that drive forward the understanding and treatment of complex neuroinflammatory diseases.

Stem Pharm - Similar Companies

Stemtech logo

Stemtech

stemtech.com

Stemgenics logo

Stemgenics

stemgenics.com

StemBioSys logo

StemBioSys

stembiosys.com

Stemina Biomarker Discovery logo

Stemina Biomarker Discovery

stemina.com

NeuCyte logo

NeuCyte

neucyte.com

Stemedica Cell Technologies logo

Stemedica Cell Technologies

stemedica.com

ImStem Biotechnology logo

ImStem Biotechnology

imstem.com

MitoStem logo

MitoStem

Humabiologics logo

Humabiologics

humabiologics.com

BrainXell logo

BrainXell

brainxell.com

APstem Therapeutics logo

APstem Therapeutics

apstemtx.com

Personalized Stem Cells logo

Personalized Stem Cells

StemSave logo

StemSave

stemsave.com

International Stem Cell logo

International Stem Cell

Stemson Therapeutics logo

Stemson Therapeutics

stemsontx.com

Stem Pharm - Quick Facts

Who are Stem Pharm's competitors?

Companies similar to Stem Pharm include Stemtech, Stemgenics, StemBioSys and Stemina Biomarker Discovery.

When was Stem Pharm founded?

Stem Pharm was founded in 2015.

Where is Stem Pharm's headquarters located?

Stem Pharm's headquarters is located in Madison, WI, US.

When was Stem Pharm's last funding round?

Stem Pharm's most recent funding round was for $10k (USD) in May 2023.

How much has Stem Pharm raised to-date?

As of May 30, 2023, Stem Pharm has raised a total of $683.3k (USD).

How many employees does Stem Pharm have?

Stem Pharm has 6 employees as of Feb 4, 2024.

Stem Pharm - Classification

Industry
  • Professional Service Companies
Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
Main Product
  • Biomaterials
  • Drug Discovery
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified